This webinar explores the challenges of managing intra-abdominal candidiasis (IAC) and the potential role of rezafungin. Designed for surgeons and other healthcare professionals, the session reviews current treatment recommendations, emerging clinical evidence, and considerations for transitioning patients from hospital to outpatient care.
Participants will gain insights to help them:
Speakers

Luis Ostrosky-Zeichner
MD, FACP, FIDSA, FSHEA, FECMM, CMQ
UTHealth Houston
ID Physician
Dr. Ostrosky-Zeichner received his medical degree from Universidad Nacional Autonoma de Mexico, completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, and his infectious diseases fellowship at the University of Texas Health Science Center at Houston/MD Anderson Cancer Center combined program.
He is currently a Professor of Medicine and Epidemiology and the Memorial Hermann Endowed Chair at the University of Texas Health Science Center at Houston, where he is appointed as the Vice Chairman of Medicine for Healthcare Quality and the Division Chief at the Division of Infectious Diseases.
He also serves as the Chief Epidemiology Officer for the Memorial Hermann Healthcare System. He has consulted for the FDA and the CDC. He has published over 250 peer-reviewed articles and actively pursues translational and clinical research in medical mycology, transplant infectious diseases, healthcare epidemiology, and antimicrobial stewardship.
Jared M. Huston
MD, FACS, FSIS, SMNAI
Northwell Health
